SCHEMBL7192138

SCHEMBL7192138

N#Cc1ccc(Oc2ccccc2NC(=O)c2cccc([N+](=O)[O-])c2)cc1-c1nnn[nH]1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.58
PYGL P06737 13/20 0.56
PYGM P11217 2/20 0.56
SIRT2 Q8IXJ6 2/20 0.46
SIRT1 Q96EB6 2/20 0.46
SIRT3 Q9NTG7 2/20 0.46
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CRHBP P24387 1/20 0.44
HTT P42858 1/20 0.44
CRHR2 Q13324 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.44
HSP90AA1 P07900 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7118162 0.94 MAPT (0.58) MAPTPYGLPYGMSIRT2SIRT1
SCHEMBL7126561 0.84 MAPT (0.72) MAPTPYGLPYGMSIRT2SIRT1
SCHEMBL7116112 0.81 PLA2G7 (0.40) MAPTPYGLPYGMALDH1A1KDM4E
SCHEMBL7657400 0.81 LMNA (0.51) MAPTPYGLALDH1A1MEN1KMT2A
SCHEMBL6432142 0.76 MAPT (0.70) MAPTPYGLPYGMSIRT2SIRT1
SCHEMBL7129337 0.75 TP53 (0.41) MAPTPYGLPYGMALDH1A1KMT2A
SCHEMBL7126028 0.73 MAPT (0.83) MAPTPYGLPYGMSIRT2SIRT1
SCHEMBL27716705 0.73 MAPT (0.87) MAPTPYGLPYGMALDH1A1MEN1
SCHEMBL4323472 0.73 PYGL (1.00) MAPTPYGLPYGM
SCHEMBL7124027 0.72 MAPT (0.81) MAPTPYGLPYGMSIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6590118-B1 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes) NOVO NORDISK A/S (DK) 2003-07-08 US disclosed